Summary
The stable isotope-labeled compound 3',-3'-dideuteronicotine (nicotine-d2) was used to investigate the disposition kinetics and effects of nicotine administered subcutaneously to 6 smokers. Plasma nicotine-d2 concentrations were measured for 8 h after subcutaneous injection of 4 doses (0.4, 0.8, 1.2, and 2.4 mg).
Peak plasma nicotine concentration correlated well with the dose, averaging 2.8 to 14.8 ng/ml, 19 to 25 min after injection of the 0.4 mg and 2.4 mg doses, respectively. The plasma clearance over bioavailability ratio (CL/f) averaged 12 to 13 ml · min−1 · kg−1, similar to the clearance reported previously for intravenously administered nicotine. Thus, bioavailability appears to be approximately 100%. The heart rate response was more sensitive to the nicotine dose than the blood pressure response. Subjective effects showed large interindividual variability.
The results reported herein may be useful in planning future studies. Administration of nicotine by the subcutaneous route appears to be a practical and safe method for studying the human pharmacology of nicotine.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Benowitz NL, Porchet H, Jacob P, III (1990) Pharmacokinetics, metabolism, and pharmacodynamics of nicotine. In: Wonnacott S, Russell MAH, Stolerman IP (eds) Nicotine psychopharmacology: molecular, cellular, and behavioural aspects. Oxford University Press, Oxford, pp 112–157
Le Houezec J, Benowitz NL (1991) Basic and clinical psychopharmacology of nicotine. Clin Chest Med 12: 681–699
Benowitz NL, Porchet H, Sheiner L (1988) Nicotine absorption and cardiovascular effect with smokeless tobacco use: comparison with cigarettes and nicotine gum. Clin Pharmacol Ther 44: 23–28
Sahakian B, Jones G, Levy R, Gray J, Warburton D (1989) The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type. Br J Psychiatry 154: 797–800
Russell MAH, Jarvis MJ, Jones G, Feyerabend C (1990) Nonsmokers show acute tolerance to subcutaneous nicotine. Psychopharmacology 102: 56–58
Benowitz NL, Jacob P, III, Denaro C, Jenkins R (1991) Stable isotope studies of nicotine kinetics and bioavailability. Clin Pharmacol Ther 49: 270–277
Fagerström K-O (1978) Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav 3: 235–241
Jacob P, III, Yu L, Wilson M, Benowitz NL (1991) Selected ion monitoring method for determination of nicotine, cotinine, and deuterium-labeled analogs: absence of an isotope effect in the clearance of (S)-nicotine-3′-3′d2 in humans. Biomed Environ Mass Spectrom 20: 247–252
Holford N (1990) MKMODEL. Biosoft, Milltown NJ
Schwartz G (1978) Estimating the dimension of a model. Ann Stat 6: 461–464
Benowitz NL, Jacob P, III, Jones RT, Rosenberg J (1982) Interindividual variability in the metabolism and cardiovascular effects of nicotine in man. J Pharmacol Exp Ther 221: 368–372
Feyerabend C, Ings RMJ, Russell MAH (1985) Nicotine pharmacokinetics and its application to intake from smoking. Br J Clin Pharmacol 19: 239–247
Rosenberg J, Benowitz NL, Jacob P, III, Wilson M (1980) Disposition kinetics and effects of intravenous nicotine. Clin Pharmacol Ther 28: 516–522
Lee BL, Benowitz NL, Jacob P, III (1987) Influence of tobacco abstinence on the disposition kinetics and effects of nicotine. Clin Pharmacol Ther 41: 474–479
Le Houezec J, Halliday R, Naylor H, Herzig K, Callaway E, Benowitz NL. Effects of nicotine on reaction time and evoked potentials in nonsmokers performing a cognitive task (submitted for publicaton)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Le Houezec, J., Jacob, P. & Benowitz, N.L. A clinical pharmacological study of subcutaneous nicotine. Eur J Clin Pharmacol 44, 225–230 (1993). https://doi.org/10.1007/BF00271362
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00271362